- Home
- ERAS vs LASR Comparison
ERAS vs LASR Comparison
Compare ERAS & LASR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- LASR
- Stock Information
- Founded
- ERAS 2018
- LASR 2000
- Country
- ERAS United States
- LASR United States
- Employees
- ERAS N/A
- LASR N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- LASR Semiconductors
- Sector
- ERAS Health Care
- LASR Technology
- Exchange
- ERAS Nasdaq
- LASR Nasdaq
- Market Cap
- ERAS 348.4M
- LASR 412.8M
- IPO Year
- ERAS 2021
- LASR 2018
- Fundamental
- Price
- ERAS $1.37
- LASR $17.40
- Analyst Decision
- ERAS Strong Buy
- LASR Strong Buy
- Analyst Count
- ERAS 6
- LASR 4
- Target Price
- ERAS $4.83
- LASR $16.13
- AVG Volume (30 Days)
- ERAS 1.7M
- LASR 951.4K
- Earning Date
- ERAS 08-11-2025
- LASR 07-31-2025
- Dividend Yield
- ERAS N/A
- LASR N/A
- EPS Growth
- ERAS N/A
- LASR N/A
- EPS
- ERAS N/A
- LASR N/A
- Revenue
- ERAS N/A
- LASR $205,689,000.00
- Revenue This Year
- ERAS N/A
- LASR $13.20
- Revenue Next Year
- ERAS N/A
- LASR $8.66
- P/E Ratio
- ERAS N/A
- LASR N/A
- Revenue Growth
- ERAS N/A
- LASR 2.66
- 52 Week Low
- ERAS $1.01
- LASR $6.20
- 52 Week High
- ERAS $3.45
- LASR $19.44
- Technical
- Relative Strength Index (RSI)
- ERAS 46.81
- LASR 62.88
- Support Level
- ERAS $1.31
- LASR $17.45
- Resistance Level
- ERAS $1.59
- LASR $19.44
- Average True Range (ATR)
- ERAS 0.13
- LASR 0.92
- MACD
- ERAS -0.02
- LASR -0.17
- Stochastic Oscillator
- ERAS 25.00
- LASR 53.59
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About LASR nLIGHT Inc.
nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA.